This article first appeared on GuruFocus.

Revolution Medicines Inc (NASDAQ:RVMD) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $0.00169 billion, and the earnings are expected to come in at -$1.38 per share. The full year 2025's revenue is expected to be $0.0039 billion and the earnings are expected to be -$5.28 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 4 Warning Sign with RVMD.

Is RVMD fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for Revolution Medicines Inc (NASDAQ:RVMD) have declined from $0.00844 billion to $0.0039 billion for the full year 2025. For 2026, revenue estimates decreased from $0.02823 billion to $0.02487 billion over the past 90 days. Earnings estimates for Revolution Medicines Inc (NASDAQ:RVMD) have declined from -$4.57 per share to -$5.28 per share for the full year 2025. For 2026, earnings estimates decreased from -$4.97 per share to -$5.83 per share over the past 90 days.

In the previous quarter of 2025-06-30, Revolution Medicines Inc's (NASDAQ:RVMD) actual revenue was $0 million, which missed analysts' revenue expectations of $0.00281 billion by -100%. Revolution Medicines Inc's (NASDAQ:RVMD) actual earnings were -$1.31 per share, which missed analysts' earnings expectations of -$1.139 per share by -15.01%. After releasing the results, Revolution Medicines Inc (NASDAQ:RVMD) was down by -4.69% in one day.

Based on the one-year price targets offered by 19 analysts, the average target price for Revolution Medicines Inc (NASDAQ:RVMD) is $77.53 with a high estimate of $99 and a low estimate of $66. The average target implies an upside of 30.67% from the current price of $59.33.

Based on GuruFocus estimates, the estimated GF Value for Revolution Medicines Inc (NASDAQ:RVMD) in one year is $8.64, suggesting a downside of -85.44% from the current price of $59.33.

Based on the consensus recommendation from 21 brokerage firms, Revolution Medicines Inc's (NASDAQ:RVMD) average brokerage recommendation is currently 1.6, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.